Charles Albert Depasse

Takeda AS operates as a pharmaceutical company. It manufactures and distributes generic medicines. The firm offers therapeutics in the areas such as cardiology, gastroenterology, osteoporosis, respiratory, and pain and tissue management. The company founded by Morten Nyegaard in 1874 and is headquartered in Asker, Norway.

Takeda Oy manufactures pharmaceutical products. The company offers prescription and over-the-counter medicines, as well as hospital products. Its core therapeutical areas are inflammatory bowel, respiratory and cardiovascular diseases, pain management, and cancer. Takeda was founded in 1946 and is headquartered in Helsinki, Finland.

Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark.

Part of PricewaterhouseCoopers International Ltd., Coopers & Lybrand (London) is a British company that provides accounting services. The company is based in Edinburgh, UK.

Takeda Pharmaceuticals International GmbH develops, manufactures, and distributes pharmaceutical products. It offers medicines in therapeutic areas, such as, cardiovascular and metabolic, oncology, central nervous system, respiratory and immunology, general medicine, and vaccines. The firm also provides packaging, development, contract manufacturing and quality control services. Takeda Pharmaceuticals International was founded in 1874 and is headquartered in Zurich, Switzerland.

Part of Svendsen Eksos Skien AS, Norsk Kjededrift AS operates as a holding company for Svendsen Eksos AS. The company is based in Skien, Norway.

Takeda Pharma A/S operates as a pharmaceutical company that provides medicines and products for hospitals, specialists, and general practitioners. It supplies prescription and non-prescription medicines for oncology and gastroenterology diseases. The company was founded on January 2, 1984 and is headquartered in Taastrup, Denmark.

Conceptomed AS specializes in maximizing flexibility and adaptability for Test-and-Trace operations. The Norwegian company's focus is on utilizing existing PCR diagnostic systems with the highest sensitivity.

S E Holding AS invests in shares. The company was founded on November 28, 2005 and is headquartered in Trondheim, Norway.